Pulmonary Blastoma

This is a rare type of cancer in the lung. It starts in the lung tissue and is made up of immature, abnormal cells. It's considered a malignant cancer.

Condition

What people with Pulmonary Blastoma report

Every report comes from a Lived member, sent anonymously.

Have you had Pneumonectomy for Pulmonary Blastoma?

NameHow it went

About Pulmonary Blastoma

What It Is

Pulmonary blastoma is a very rare and aggressive cancer that starts in the lung. Under the microscope, it is made of immature cells that resemble the tissue of a developing fetal lung, usually in two forms at once: cells like those lining the airways and cells like connective tissue. This two-part pattern is why the classic adult form is called classic biphasic pulmonary blastoma. It makes up well under 1 percent of lung tumors, so most doctors see few, if any, cases. The name has been used for more than one disease, which can make reading about it confusing. In 2021, the World Health Organization classification of lung tumors separated three tumors that used to be grouped together. The adult classic biphasic form is now treated as a type of sarcomatoid carcinoma, a group of uncommon lung cancers that contain both carcinoma-like and sarcoma-like cells. Well-differentiated fetal adenocarcinoma is now grouped with ordinary lung adenocarcinomas. Pleuropulmonary blastoma, which affects infants and young children, is a separate tumor with its own treatment and genetic implications. This page mainly describes the adult tumor.

Causes & Risk Factors

The cause of pulmonary blastoma is not known. Some reports link it to smoking, and many people diagnosed have smoked, but the association has not been firmly established and the disease also occurs in people who never smoked. Studies disagree on whether it is more common in men or women, and it has been found at a wide range of ages. Researchers studying tumor tissue have found changes in genes that guide early development, particularly CTNNB1 (which makes beta-catenin) and DICER1 (a gene that helps control how other genes are switched on and off). These changes arise in the tumor itself and help pathologists recognize it; they are not a known inherited risk for the adult form. Pleuropulmonary blastoma in children is different: more than 70 percent of cases occur in children who carry an inherited DICER1 variant, so genetic counseling and testing of family members are recommended when a child is diagnosed.

How It's Diagnosed

Pulmonary blastoma usually comes to attention the same way other lung cancers do. People may have a cough, chest pain or blood-streaked sputum, but about one in three has no symptoms, and the tumor is found on a chest X-ray or CT (computed tomography) scan done for another reason. On CT, it typically appears as a single, often large mass (commonly more than 5 centimeters across) toward the outer part of the lung. Imaging cannot tell pulmonary blastoma apart from more common lung cancers. The diagnosis depends on a pathologist examining tumor tissue, often with special stains that show both of the tumor's cell types. A small needle biopsy may not capture both components, so the diagnosis is sometimes made only after the tumor is surgically removed. Staging tests, such as CT scans or PET (positron emission tomography) scans, which highlight active cancer cells, and sampling of lymph nodes, show whether the cancer has spread and help decide whether surgery is possible. Because the tumor is so rare, review by a pathologist with lung cancer expertise is valuable.

Treatment Options

Surgery to remove the tumor completely, usually by taking out the affected lobe of the lung along with nearby lymph nodes, is the main treatment and the only approach with a realistic chance of cure. In published series, people whose tumors could be removed lived much longer than those whose tumors could not. There is no standard chemotherapy or radiation plan, because the disease is too rare for clinical trials. Chemotherapy, often platinum-based combinations borrowed from other lung cancers, may be given after surgery to lower the chance of the cancer returning, or before surgery to shrink a large tumor enough to remove it. In older series, roughly one in four tumors shrank with chemotherapy. Radiation may be used after surgery or when surgery is not possible. When the cancer returns in a single place, removing it again has led to long remissions for some people. For advanced disease, doctors may test the tumor for genetic changes and markers that suggest newer treatments, such as targeted drugs, medicines that block a tumor's blood supply, or immunotherapy, which helps the immune system attack cancer. Individual case reports describe good responses, but the evidence is very limited. Because experience is scarce, care at a center with a multidisciplinary lung cancer team, and asking about clinical trials, is worth considering.

What to Expect

Outlook varies widely and depends mostly on whether the tumor can be fully removed, how far it has spread at diagnosis and the person's age and overall health. Older reports described a poor prognosis, with most people surviving less than two years. A more recent United States cancer registry study using the 2021 classification found that about half of people were alive five years after diagnosis, which suggests results are better than the older figures implied, especially when the tumor can be removed. Individual outcomes cannot be predicted from these numbers. The cancer often returns, sometimes within the first year or two after surgery, so follow-up is closer than for many other cancers, with regular appointments and chest scans. Recovery from lung surgery takes several weeks, and breathing capacity afterward depends on how much lung was removed and how healthy the remaining lung is. Pulmonary rehabilitation, stopping smoking and support for the stress of a rare diagnosis can all help with day-to-day life.

When to Seek Help

See a clinician if a cough, chest pain or shortness of breath lasts more than a few weeks or keeps getting worse, especially if you smoke or have smoked. After treatment, keep scheduled scans and tell your care team promptly about new cough, chest or bone pain, unexplained weight loss, headaches or other new symptoms, since these can be early signs that the cancer has returned. Contact your care team the same day if you cough up blood or breathlessness worsens suddenly; coughing up more than a small amount of blood, or severe trouble breathing, needs emergency care.

Questions to Ask Your Doctor

  1. 1.Has a pathologist experienced with rare lung tumors confirmed that this is classic biphasic pulmonary blastoma and not another type of lung cancer?
  2. 2.What stage is the cancer, and can it be completely removed with surgery?
  3. 3.Would chemotherapy or radiation before or after surgery help in my situation, and what are the realistic benefits?
  4. 4.Should my tumor be tested for genetic changes or markers that might open up targeted therapy, immunotherapy or a clinical trial?
  5. 5.How often will I need scans after treatment, and what symptoms should prompt me to call between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.